1
|
Giladi M, Montgomery AP, Kassiou M, Danon JJ. Structure-based drug design for TSPO: Challenges and opportunities. Biochimie 2024:S0300-9084(24)00120-2. [PMID: 38782353 DOI: 10.1016/j.biochi.2024.05.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2024] [Revised: 04/27/2024] [Accepted: 05/21/2024] [Indexed: 05/25/2024]
Abstract
The translocator protein 18 kDa (TSPO) is an evolutionarily conserved mitochondrial transmembrane protein implicated in various neuropathologies and inflammatory conditions, making it a longstanding diagnostic and therapeutic target of interest. Despite the development of various classes of TSPO ligand chemotypes, and the elucidation of bacterial and non-human mammalian experimental structures, many unknowns exist surrounding its differential structural and functional features in health and disease. There are several limitations associated with currently used computational methodologies for modelling the native structure and ligand-binding behaviour of this enigmatic protein. In this perspective, we provide a critical analysis of the developments in the uses of these methods, outlining their uses, inherent limitations, and continuing challenges. We offer suggestions of unexplored opportunities that exist in the use of computational methodologies which offer promise for enhancing our understanding of the TSPO.
Collapse
Affiliation(s)
- Mia Giladi
- School of Chemistry, The University of Sydney, 2050, Sydney, NSW, Australia
| | | | - Michael Kassiou
- School of Chemistry, The University of Sydney, 2050, Sydney, NSW, Australia.
| | - Jonathan J Danon
- School of Chemistry, The University of Sydney, 2050, Sydney, NSW, Australia.
| |
Collapse
|
2
|
Adhikari A, Pandey A, Kumar D, Tiwari AK. Determination of Hybrid TSPO Ligands with Minimal Impact of SNP
(rs6971) through Molecular Docking and MD Simulation Study. LETT DRUG DES DISCOV 2022. [DOI: 10.2174/1570180818666210413130326] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Background:
In an endeavor to ascertain high-affinity TSPO ligands with minimal single
nucleotide polymorphism (SNP), six hybrid molecules have been identified as new leads for future
inflammation PET imaging.
Objective:
Genesis for chemical design was encouraged from structural families of well-known ligands
FEBMP and PBR28/ DAA1106 that have demonstrated remarkable TSPO binding characteristics.
Methods:
All proposed hybrid ligands 1-6 are subjected to molecular docking and simulation studies
with wild and mutant protein to study their interactions, binding, consistency of active conformations
and are correlated with well-established TSPO ligands.
Results:
Each hybrid ligand demonstrate better docking score > -11.00 kcal/mol with TSPO with
respect to gold standard PK11195, i.e., -11.00 kcal/mol for 4UC3 and -12.94 kcal/mol for 4UC1. On
comparison with FEBMP and GE-180 (-12.57, -7.24 kcal/mol for 4UC3 and -14.10, -11.32
kcal/mol for 4UC1), ligand 3 demonstrates maximum docking energy (> -15.50 kcal/mol) with
minimum SNP (0.26 kcal/mol).
Discussion:
Presence of strong hydrogen bond Arg148-3.27Å (4UC1) and Trp50-2.43Å, Asp28-
2.57Å (4UC3) apart from short-range interactions, including π–π interactions with the aromatic residues,
such as (Trp39, Phe46, Trp135) and (Trp39, Trp108), attributes towards its strong binding.
Conclusion:
Utilizing the results of binding energy, we concluded stable complex formation of these
hybrid ligands that could bind to TSPO with the least effect of SNP with similar interactions to
known ligands. Overall, ligand 3 stands out as the best ligand having insignificant deviations per
residue of protein that can be further explored and assessed in detail for future inflammation PET
application after subsequent detailed biological evaluation.
Collapse
Affiliation(s)
- Anupriya Adhikari
- Department of Chemistry, Babasaheb Bhimrao Ambedkar University, Lucknow, Uttar Pradesh, India
| | - Anwesh Pandey
- Department of
Physics, Babasaheb Bhimrao Ambedkar University, Lucknow, Uttar Pradesh, India
| | - Devesh Kumar
- Department of
Physics, Babasaheb Bhimrao Ambedkar University, Lucknow, Uttar Pradesh, India
| | - Anjani K. Tiwari
- Department of Chemistry, Babasaheb Bhimrao Ambedkar University, Lucknow, Uttar Pradesh, India
| |
Collapse
|
3
|
Lee SH, Denora N, Laquintana V, Mangiatordi GF, Lopedota A, Lopalco A, Cutrignelli A, Franco M, Delre P, Song IH, Kim HW, Kim SB, Park HS, Kim K, Lee SY, Youn H, Lee BC, Kim SE. Radiosynthesis and characterization of [ 18F]BS224: a next-generation TSPO PET ligand insensitive to the rs6971 polymorphism. Eur J Nucl Med Mol Imaging 2021; 49:110-124. [PMID: 34783879 PMCID: PMC8712300 DOI: 10.1007/s00259-021-05617-4] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2021] [Accepted: 11/03/2021] [Indexed: 01/03/2023]
Abstract
PURPOSE Translocator protein 18-kDa (TSPO) positron emission tomography (PET) is a valuable tool to detect neuroinflammed areas in a broad spectrum of neurodegenerative diseases. However, the clinical application of second-generation TSPO ligands as biomarkers is limited because of the presence of human rs6971 polymorphism that affects their binding. Here, we describe the ability of a new TSPO ligand, [18F]BS224, to identify abnormal TSPO expression in neuroinflammation independent of the rs6971 polymorphism. METHODS An in vitro competitive inhibition assay of BS224 was conducted with [3H]PK 11195 using membrane proteins isolated from 293FT cells expressing TSPO-wild type (WT) or TSPO-mutant A147T (Mut), corresponding to a high-affinity binder (HAB) and low-affinity binder (LAB), respectively. Molecular docking was performed to investigate the interaction of BS224 with the binding sites of rat TSPO-WT and TSPO-Mut. We synthesized a new 18F-labeled imidazopyridine acetamide ([18F]BS224) using boronic acid pinacol ester 6 or iodotoluene tosylate precursor 7, respectively, via aromatic 18F-fluorination. Dynamic PET scanning was performed up to 90 min after the injection of [18F]BS224 to healthy mice, and PET imaging data were obtained to estimate its absorbed doses in organs. To evaluate in vivo TSPO-specific uptake of [18F]BS224, lipopolysaccharide (LPS)-induced inflammatory and ischemic stroke rat models were used. RESULTS BS224 exhibited a high affinity (Ki = 0.51 nM) and selectivity for TSPO. The ratio of IC50 values of BS224 for LAB to that for HAB indicated that the TSPO binding affinity of BS224 has low binding sensitivity to the rs6971 polymorphism and it was comparable to that of PK 11195, which is not sensitive to the polymorphism. Docking simulations showed that the binding mode of BS224 is not affected by the A147T mutation and consequently supported the observed in vitro selectivity of [18F]BS224 regardless of polymorphisms. With optimal radiochemical yield (39 ± 6.8%, decay-corrected) and purity (> 99%), [18F]BS224 provided a clear visible image of the inflammatory lesion with a high signal-to-background ratio in both animal models (BPND = 1.43 ± 0.17 and 1.57 ± 0.37 in the LPS-induced inflammatory and ischemic stroke rat models, respectively) without skull uptake. CONCLUSION Our results suggest that [18F]BS224 may be a promising TSPO ligand to gauge neuroinflammatory disease-related areas in a broad range of patients irrespective of the common rs6971 polymorphism.
Collapse
Affiliation(s)
- Sang Hee Lee
- Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, 13620 Republic of Korea
- Department of Transdisciplinary Studies, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, 08826 Republic of Korea
| | - Nunzio Denora
- Department of Pharmacy – Drug Sciences, University of Bari “A. Moro”, 70121 Bari, Italy
| | - Valentino Laquintana
- Department of Pharmacy – Drug Sciences, University of Bari “A. Moro”, 70121 Bari, Italy
| | | | - Angela Lopedota
- Department of Pharmacy – Drug Sciences, University of Bari “A. Moro”, 70121 Bari, Italy
| | - Antonio Lopalco
- Department of Pharmacy – Drug Sciences, University of Bari “A. Moro”, 70121 Bari, Italy
| | - Annalisa Cutrignelli
- Department of Pharmacy – Drug Sciences, University of Bari “A. Moro”, 70121 Bari, Italy
| | - Massimo Franco
- Department of Pharmacy – Drug Sciences, University of Bari “A. Moro”, 70121 Bari, Italy
| | - Pietro Delre
- Institute of Crystallography, National Research Council, Via G. Amendola 122/O, 70126 Bari, Italy
- Department of Chemistry, University of Bari “A. Moro”, Via E. Orabona, 4, 70125 Bari, Italy
| | - In Ho Song
- Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, 13620 Republic of Korea
| | - Hye Won Kim
- Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, 13620 Republic of Korea
- Department of Transdisciplinary Studies, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, 08826 Republic of Korea
| | - Su Bin Kim
- Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, 13620 Republic of Korea
- Department of Transdisciplinary Studies, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, 08826 Republic of Korea
| | - Hyun Soo Park
- Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, 13620 Republic of Korea
| | - Kyungmin Kim
- Department of Nuclear Medicine, Seoul National University Hospital, Seoul, 03080 Republic of Korea
- Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, 03080 Republic of Korea
- Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, 03080 Republic of Korea
| | - Seok-Yong Lee
- Department of Nuclear Medicine, Seoul National University Hospital, Seoul, 03080 Republic of Korea
- Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, 03080 Republic of Korea
- Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, 03080 Republic of Korea
| | - Hyewon Youn
- Department of Nuclear Medicine, Seoul National University Hospital, Seoul, 03080 Republic of Korea
- Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, 03080 Republic of Korea
| | - Byung Chul Lee
- Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, 13620 Republic of Korea
- Center for Nanomolecular Imaging and Innovative Drug Development, Advanced Institutes of Convergence Technology, Suwon, 16229 Republic of Korea
| | - Sang Eun Kim
- Department of Nuclear Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, 13620 Republic of Korea
- Center for Nanomolecular Imaging and Innovative Drug Development, Advanced Institutes of Convergence Technology, Suwon, 16229 Republic of Korea
- Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, 08826 Republic of Korea
| |
Collapse
|
4
|
Cheng Y, Chen N, Li J, Su J, Yang J, Zhang C, Lin H, Zhou Y. Antimicrobial Chlorinated Carbazole Alkaloids from the
Sponge‐Associated
Actinomycete
Streptomyces diacarni
LHW51701. CHINESE J CHEM 2021. [DOI: 10.1002/cjoc.202000736] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Affiliation(s)
- Yijia Cheng
- School of Pharmaceutical Science Guangzhou University of Chinese Medicine Guangzhou Guangdong 510006 China
| | - Nannan Chen
- Research Center for Marine Drugs, State Key Laboratory of Oncogenes and Related Genes, Department of Pharmacy, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai 200127 China
| | - Jing Li
- College of Food Science and Technology, Shanghai Ocean University Shanghai 201306 China
| | - Jun‐Cheng Su
- Research Center for Marine Drugs, State Key Laboratory of Oncogenes and Related Genes, Department of Pharmacy, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai 200127 China
| | - Jingya Yang
- College of Food Science and Technology, Shanghai Ocean University Shanghai 201306 China
| | - Cui‐Xian Zhang
- School of Pharmaceutical Science Guangzhou University of Chinese Medicine Guangzhou Guangdong 510006 China
| | - Hou‐Wen Lin
- Research Center for Marine Drugs, State Key Laboratory of Oncogenes and Related Genes, Department of Pharmacy, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai 200127 China
| | - Yongjun Zhou
- Research Center for Marine Drugs, State Key Laboratory of Oncogenes and Related Genes, Department of Pharmacy, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai 200127 China
| |
Collapse
|
5
|
Danon JJ, Tregeagle DFL, Kassiou M. Adventures in Translocation: Studies of the Translocator Protein (TSPO) 18 kDa. Aust J Chem 2021. [DOI: 10.1071/ch21176] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
The 18 kDa translocator protein (TSPO) is an evolutionarily conserved transmembrane protein found embedded in the outer mitochondrial membrane. A secondary target for the benzodiazepine diazepam, TSPO has been a protein of interest for researchers for decades, particularly owing to its well-established links to inflammatory conditions in the central and peripheral nervous systems. It has become a key biomarker for assessing microglial activation using positron emission tomography (PET) imaging in patients with diseases ranging from atherosclerosis to Alzheimer’s disease. This Account describes research published by our group over the past 15 years surrounding the development of TSPO ligands and their use in probing the function of this high-value target.
Collapse
|
6
|
Moir M, Lane S, Montgomery AP, Hibbs D, Connor M, Kassiou M. The discovery of a potent and selective pyrazolo-[2,3-e]-[1,2,4]-triazine cannabinoid type 2 receptor agonist. Eur J Med Chem 2020; 210:113087. [PMID: 33321261 DOI: 10.1016/j.ejmech.2020.113087] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2020] [Revised: 12/01/2020] [Accepted: 12/03/2020] [Indexed: 11/26/2022]
Abstract
The development of selective CB2 receptor agonists is a promising therapeutic approach for the treatment of inflammatory diseases, without CB1 receptor mediated psychoactive side effects. Preliminary structure-activity relationship studies on pyrazoylidene benzamide agonists revealed the -ylidene benzamide moiety was crucial for functional activity at the CB2 receptor. A small library of compounds with varying linkage moieties between the pyrazole and substituted phenyl group has culminated in the discovery of a potent and selective pyrazolo-[2,3-e]-[1,2,4]-triazine agonist 19 (CB2R EC50 = 19 nM, CB1R EC50 > 10 μM). Docking studies have revealed key structural features of the linkage group that are important for potent functional activity.
Collapse
Affiliation(s)
- Michael Moir
- School of Chemistry, The University of Sydney, NSW, 2006, Australia
| | - Samuel Lane
- Faculty of Health Sciences, The University of Sydney, NSW, 2006, Australia
| | | | - David Hibbs
- Sydney Pharmacy School, The University of Sydney, NSW, 2006, Australia
| | - Mark Connor
- Department of Biomedical Sciences, Macquarie University, NSW, 2109, Australia
| | - Michael Kassiou
- School of Chemistry, The University of Sydney, NSW, 2006, Australia.
| |
Collapse
|
7
|
Sokias R, Werry EL, Alison Cheng HW, Lloyd JH, Sohler G, Danon JJ, Montgomery AP, Du JJ, Gao Q, Hibbs DE, Ittner LM, Reekie TA, Kassiou M. Tricyclic heterocycles display diverse sensitivity to the A147T TSPO polymorphism. Eur J Med Chem 2020; 207:112725. [DOI: 10.1016/j.ejmech.2020.112725] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2020] [Revised: 08/02/2020] [Accepted: 08/03/2020] [Indexed: 12/11/2022]
|
8
|
Effects of dietary fiber on the digestion and structure of gluten under different thermal processing conditions. Food Hydrocoll 2020. [DOI: 10.1016/j.foodhyd.2020.106080] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
9
|
An update into the medicinal chemistry of translocator protein (TSPO) ligands. Eur J Med Chem 2020; 209:112924. [PMID: 33081988 DOI: 10.1016/j.ejmech.2020.112924] [Citation(s) in RCA: 29] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2020] [Revised: 10/06/2020] [Accepted: 10/06/2020] [Indexed: 01/16/2023]
Abstract
The Translocator Protein 18 kDa (TSPO) has been discovered in 1977 as an alternative binding site for the benzodiazepine diazepam. It is an evolutionary well-conserved and tryptophan-rich 169-amino acids protein with five alpha helical transmembrane domains stretching the outer mitochondrial membrane, with the carboxyl-terminus in the cytosol and a short amino-terminus in the intermembrane space of mitochondrion. At this level, together with the voltage-dependent anion channel (VDAC) and the adenine nucleotide translocase (ANT), it forms the mitochondrial permeability transition pore (MPTP). TSPO expression is ubiquitary, with higher levels in steroid producing tissues; in the central nervous system, it is mainly expressed in glial cells and in neurons. TSPO is implicated in a variety of fundamental cellular processes including steroidogenesis, heme biosynthesis, mitochondrial respiration, mitochondrial membrane potential, cell proliferation and differentiation, cell life/death balance, oxidative stress. Altered TSPO expression has been found in some pathological conditions. In particular, high TSPO expression levels have been documented in cancer, neuroinflammation, and brain injury. Conversely, low TSPO expression levels have been evidenced in anxiety disorders. Therefore, TSPO is not only an interesting drug target for therapeutic purpose (anticonvulsant, anxiolytic, etc.), but also a valid diagnostic marker of related-diseases detectable by fluorescent or radiolabeled ligands. The aim of this report is to present an update of previous reviews dealing with the medicinal chemistry of TSPO and to highlight the most outstanding advances in the development of TSPO ligands as potential therapeutic or diagnostic tools, especially referring to the last five years.
Collapse
|
10
|
Tian X, Song L, Hashmi ASK. Synthesis of Carbazoles and Related Heterocycles from Sulfilimines by Intramolecular C-H Aminations. Angew Chem Int Ed Engl 2020; 59:12342-12346. [PMID: 32045085 PMCID: PMC7384176 DOI: 10.1002/anie.202000146] [Citation(s) in RCA: 33] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2020] [Indexed: 01/28/2023]
Abstract
While direct nitrene insertions into C-H bonds have become an important tool for building C-N bonds in modern organic chemistry, the generation of nitrene intermediates always requires transition metals, high temperatures, ultraviolet or laser light. We report a mild synthesis of carbazoles and related building blocks through a visible light-induced intramolecular C-H amination reaction. A striking advantage of this new method is the use of more reactive aryl sulfilimines instead of the corresponding hazardous azides. Different catalysts and divergent light sources were tested. The reaction scope is broad and the product yield is generally high. An efficient gram-scale synthesis of Clausine C demonstrates the applicability and scalability of this new method.
Collapse
Affiliation(s)
- Xianhai Tian
- Institut für Organische ChemieHeidelberg UniversityIm Neuenheimer Feld 27069120HeidelbergGermany
| | - Lina Song
- Institut für Organische ChemieHeidelberg UniversityIm Neuenheimer Feld 27069120HeidelbergGermany
| | - A. Stephen K. Hashmi
- Institut für Organische ChemieHeidelberg UniversityIm Neuenheimer Feld 27069120HeidelbergGermany
- Chemistry DepartmentFaculty of ScienceKing Abdulaziz UniversityJeddah21589Saudi Arabia
| |
Collapse
|
11
|
Tian X, Song L, Hashmi ASK. Synthese von Carbazolen und Verwandten Heterocyclen aus Sulfiliminen durch Intramolekulare C‐H‐Aminierungen. Angew Chem Int Ed Engl 2020. [DOI: 10.1002/ange.202000146] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Xianhai Tian
- Institut für Organische Chemie Universität Heidelberg Im Neuenheimer Feld 270 69120 Heidelberg Deutschland
| | - Lina Song
- Institut für Organische Chemie Universität Heidelberg Im Neuenheimer Feld 270 69120 Heidelberg Deutschland
| | - A. Stephen K. Hashmi
- Institut für Organische Chemie Universität Heidelberg Im Neuenheimer Feld 270 69120 Heidelberg Deutschland
- Chemistry Department Faculty of Science King Abdulaziz University Jeddah 21589 Saudi Arabia
| |
Collapse
|
12
|
Vo SV, Banister SD, Freelander I, Werry EL, Reekie TA, Ittner LM, Kassiou M. Reversing binding sensitivity to A147T translocator protein. RSC Med Chem 2020; 11:511-517. [PMID: 33479652 PMCID: PMC7489257 DOI: 10.1039/c9md00580c] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2019] [Accepted: 02/22/2020] [Indexed: 11/21/2022] Open
Abstract
The translocator protein (TSPO) is a target for the development of neuroinflammation imaging agents. Clinical translation of TSPO PET ligands, such as [11C]DPA-713, has been hampered by the presence of a common polymorphism (A147T TSPO), at which all second-generation TSPO ligands lose affinity. Little is known about what drives binding at A147T compared to WT TSPO. This study aimed to identify moieties in DPA-713, and related derivatives, that influence binding at A147T compared to WT TSPO. We found changes to the nitrogen position and number in the heterocyclic core influences affinity to WT and A147T to a similar degree. Hydrogen bonding groups in molecules with an indole core improve binding at A147T compared to WT, a strategy that generated compounds that possess up to ten-times greater affinity for A147T. These results should inform the future design of compounds that bind both A147T and WT TSPO for use in neuroinflammation imaging.
Collapse
Affiliation(s)
- Sophie V Vo
- Faculty of Medicine and Health , The University of Sydney , Sydney , New South Wales 2006 , Australia
| | - Samuel D Banister
- The Lambert Initiative for Cannabinoid Therapeutics , Brain and Mind Centre , The University of Sydney , Camperdown , NSW 2050 , Australia
- School of Chemistry , The University of Sydney , Sydney , New South Wales 2006 , Australia .
| | - Isaac Freelander
- School of Chemistry , The University of Sydney , Sydney , New South Wales 2006 , Australia .
| | - Eryn L Werry
- School of Chemistry , The University of Sydney , Sydney , New South Wales 2006 , Australia .
| | - Tristan A Reekie
- Research School of Chemistry , The Australian National University , Canberra , Australian Capital Territory 2600 , Australia
| | - Lars M Ittner
- Department of Biomedical Sciences , Faculty of Medicine and Health Sciences , Macquarie University , 2 Technology Place , North Ryde , New South Wales 2109 , Australia
| | - Michael Kassiou
- School of Chemistry , The University of Sydney , Sydney , New South Wales 2006 , Australia .
| |
Collapse
|